Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (231)

« Back to Publications

Myasthenic syndromes: mistaking genetic for acquired

Henehan L. et al, (2026), Practical Neurology, 26, 164 - 168

Predictive factors for immunosuppression-associated severe and opportunistic infections in AQP4-IgG Neuromyelitis Optica Spectrum Disorder

Greco G. et al, (2026), Multiple Sclerosis Journal, 32, 326 - 337

Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD.

Rotstein DL. et al, (2026), Lancet Neurol, 25, 308 - 324

Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis.

Dodd KC. et al, (2026), Med

Frequent co-occurrence of AChR-positive myasthenia gravis in facioscapulohumeral muscular dystrophy suggests a novel disease association.

McMacken G. et al, (2026), J Neurol Neurosurg Psychiatry

CASPR2 Autoimmune Antibodies Induce Neuronal Hyperactivity in Human Brain Organoids.

Oliveira AR. et al, (2026), J Neurochem, 170

CAR-T cells in the treatment of neurological autoimmune diseases

Vonberg FW. et al, (2026), Practical Neurology

The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis

Al-Diwani A. et al, (2026), The Lancet Psychiatry, 13, 47 - 61

Defining the Clinical Target Volume in Postoperative Thymic Epithelial Tumours - A Clinical Practice Guide for UK Clinical Oncologists.

Robinson SD. et al, (2026), Clin Oncol (R Coll Radiol), 49

Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica

Salih H. et al, (2025), Annals of Clinical and Translational Neurology

Plasma N -Glycan Profiling Enhances Diagnostic Precision in Multiple Sclerosis, AQP4-Ab NMOSD, and MOGAD

Kacerova T. et al, (2025), Neurology Neuroimmunology & Neuroinflammation, 12

Self-administration of rozanolixizumab via manual push and infusion pump methods in patients with generalised myasthenia gravis: a randomised, phase 3, open-label, crossover study.

Bril V. et al, (2025), J Neurol, 272

Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update).

Jacob S. et al, (2025), Pract Neurol, 25, 422 - 437

Quantitative analysis of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies titres: correlation with relapses

Nasello M. et al, (2025), Brain Communications, 7

The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD

Samadzadeh S. et al, (2025), Journal of Neurology, 272

Load More

1
2
3
4
5
6
7
...
»